<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. _____)*
AmeriSource Health Corporation
- -----------------------------------------------------------------
(Name of Issuer)
Common Stock
- -----------------------------------------------------------------
(Title of Class of Securities)
03071P102
-------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement
[ ]. (A fee is not required only if the filing person: (1) has a
previous statement on file reporting beneficial ownership of more than
five percent of the class of securities described in Item 1; and
(2) has filed no amendment subsequent thereto reporting beneficial
ownership of five percent or less of such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
Page 1 of 11 pages<PAGE>
CUSIP No. 03071P102 13G Page 2 of 11 Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Berger Associates, Inc. ID No. 13-2750052
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5 SOLE VOTING POWER
-0-
6 SHARED VOTING POWER
900,100
7 SOLE DISPOSITIVE POWER
-0-
8 SHARED DISPOSITIVE POWER
900,100
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
900,100
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
N/A
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.3%
12 TYPE OF REPORTING PERSON
IA, CO
<PAGE>
CUSIP No. 03071P102 13G Page 3 of 11 Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kansas City Southern Industries, Inc. ID No. 44-0663509
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5 SOLE VOTING POWER
-0-
6 SHARED VOTING POWER
-0-
7 SOLE DISPOSITIVE POWER
-0-
8 SHARED DISPOSITIVE POWER
-0-
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-0-
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
Excludes shares beneficially owned by Berger Associates, Inc. as
to which beneficial ownership is disclaimed. [X]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
12 TYPE OF REPORTING PERSON
HC, CO
<PAGE>
SCHEDULE 13G Page 4 of 11
- ----------------------------------------------------------------------
CUSIP No. 03071P102 AmeriSource Health Corporation
- ----------------------------------------------------------------------
Item 1.
(a) Name of Issuer: AmeriSource Health Corporation
(b) Address of Issuer's Principal Executive Offices:
300 Chesterfield Parkway
Malvern, PA 19355
Item 2.
(a) Name of Person Filing:
(1) Berger Associates, Inc.
(2) Kansas City Southern Industries, Inc.
(b) Address of Principal Business Office:
(1) Berger Associates, Inc.
210 University Boulevard, Suite 900
Denver, Colorado 80206
(2) Kansas City Southern Industries, Inc.
114 West 11th Street
Kansas City, MO 64105
(c) Citizenship:
(1) Berger Associates, Inc.: Delaware
(2) Kansas City Southern Industries, Inc.: Delaware
(d) Title of Class of Securities: Common Stock
(e) CUSIP Number: 03071P102
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or
13d-2(b), check whether the person filing is a:
(a) ____ Broker or Dealer registered under Section 15 of the Act
(b) ____ Bank as defined in section 3(a)(6) of the Act
(c) ____ Insurance Company as defined in section 3(a)(19) of the
Act
(d) ____ Investment Company registered under section 8 of the
Investment Company Act
<PAGE>
SCHEDULE 13G Page 5 of 11
- ----------------------------------------------------------------------
CUSIP No. 03071P102 AmeriSource Health Corporation
- ----------------------------------------------------------------------
(e) X Investment Adviser registered under section 203 of the
---- Investment Advisers Act of 1940/1/
(f) ____ Employee Benefit Plan, Pension Fund which is subject to
the provisions of the Employee Retirement Income
Security Act of 1974 or Endowment Fund; see
section 240.13d-1(b)(1)(ii)(F)
(g) X Parent Holding Company, in accordance with section
---- 240.13d-1(b)(1)(ii)(G) (Note: See Item 7)/2/
(h) ____ Group, in accordance with section
240.13d-1(b)(1)(ii)(H)
Item 4. Ownership
(a) Amount Beneficially Owned:
(1) Berger Associates, Inc.: 900,100*
-------
*The filing of this statement shall not be construed as
an admission that Berger Associates, Inc. is, for
purposes of Sections 13(d) or 13(g) of the Securities
Exchange Act of 1934, the beneficial owner of any
securities covered by this statement.
Berger Associates, Inc. is a registered investment
adviser which furnishes investment advice to nine
mutual funds and to individual and institutional
clients. The mutual funds, The One Hundred Fund, Inc.;
the Berger One Hundred and One Fund, Inc., dba the
Berger Growth and Income Fund, Inc.; two series of the
Berger Investment Portfolio Trust: (1) the Berger
Small Company Growth Fund, and (2) the Berger New
Generation Fund; three series of the Berger
Institutional Products Trust: (1) the One Hundred
Fund, Inc., (2) the Berger One Hundred and One Fund,
Inc., dba the Berger Growth and Income Fund, Inc., and
(3) the Berger Small Company Growth Fund; the New
England Star Advisers Fund, a series of New England
Funds Trust I; and the Berger
- ----------------------------
/1/ Berger Associates, Inc. is a registered investment adviser.
/2/ Kansas City Southern Industries, Inc. ("KCSI") is the parent
holding company of Berger Associates, Inc. KCSI owns approxi-
mately 87% of Berger Associates, Inc. and is filing this
statement solely as a result of such stock ownership which may
be deemed to give KCSI control over Berger Associates, Inc.
<PAGE>
SCHEDULE 13G Page 6 of 11
- ----------------------------------------------------------------------
CUSIP No. 03071P102 AmeriSource Health Corporation
- ----------------------------------------------------------------------
Capital Growth Portfolio, a series of American Skandia
Trust (collectively, the "Funds"), are open-end
management investment companies registered under the
Investment Company Act of 1940.
As a result of its role as investment adviser or sub-
adviser to the Funds, Berger Associates, Inc. may be
deemed to be the beneficial owner of securities held by
such funds.
(2) Kansas City Southern Industries, Inc.: 0**
--------
**Kansas City Southern Industries, Inc. ("KCSI") does
not own of record any shares of AmeriSource Health
Corporation Common Stock, it has not engaged in any
transaction in AmeriSource Health Corporation Common
Stock, and it does not exercise any voting or invest-
ment power over shares of AmeriSource Health
Corporation Common Stock. All shares reported herein
have been acquired by Berger Associates, Inc.'s mutual
fund clients and KCSI specifically disclaims beneficial
ownership over any shares of AmeriSource Health
Corporation Common Stock.
Accordingly, the filing of this statement shall not be
construed as an admission that KCSI is, for purposes of
Sections 13(d) or 13(g) of the Securities Exchange Act
of 1934, the beneficial owner of any securities covered
by this statement.
(b) Percent of Class:
(1) Berger Associates, Inc.: 5.3%*
---
*The filing of this statement shall not be construed as
an admission that Berger Associates, Inc. is, for
purposes of Sections 13(d) or 13(g) of the Securities
Exchange Act of 1934, the beneficial owner of any
securities covered by this statement.
(2) Kansas City Southern Industries, Inc. 0.0%**
---
** See Item 4(a)(2).
<PAGE>
SCHEDULE 13G Page 7 of 11
- ----------------------------------------------------------------------
CUSIP No. 03071P102 AmeriSource Health Corporation
- ----------------------------------------------------------------------
(c) Number of shares as to which such person has:
(1) Berger Associates, Inc.:
(i) sole power to vote or to direct the vote
0
------
(ii) shared power to vote or to direct the vote
900,100
-------
(iii) sole power to dispose or to direct the
disposition of
0
------
(iv) shared power to dispose or to direct the
disposition of
900,100
-------
(2) Kansas City Southern Industries, Inc.
(i) sole power to vote or to direct the vote
0
------
(ii) shared power to vote or to direct the vote
0*
------
(iii) sole power to dispose or to direct the
disposition of
0
------
(iv) shared power to dispose or to direct the
disposition of
0*
------
* See Item 4(a)(2).
Item 5. Ownership of Five Percent or Less of a Class
N/A
<PAGE>
SCHEDULE 13G Page 8 of 11
- ----------------------------------------------------------------------
CUSIP No. 03071P102 AmeriSource Health Corporation
- ----------------------------------------------------------------------
Item 6. Ownership of More than Five Percent on Behalf of Another
Person
N/A
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent
Holding Company
This statement has been filed jointly by KCSI (parent
holding company) and Berger Associates, Inc. (its registered
investment adviser subsidiary) and information relating to
Berger Associates, Inc. has been included herein.
Item 8. Identification and Classification of Members of the Group
N/A
Item 9. Notice of Dissolution of Group
N/A
Item 10. Certification
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired
in the ordinary course of business and were not acquired for
the purpose of and do not have the effect of changing or
influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in
any transaction having such purposes or effect.
<PAGE>
SCHEDULE 13G Page 9 of 11
- ----------------------------------------------------------------------
CUSIP No. 03071P102 AmeriSource Health Corporation
- ----------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
BERGER ASSOCIATES, INC.:
February 12, 1997
-----------------------------------
Date
KEVIN R. FAY
-----------------------------------
Signature
Kevin R. Fay, Sr. Vice President -
Finance and Administration
-----------------------------------
Name/Title
KANSAS CITY SOUTHERN INDUSTRIES,
INC.
February 12, 1997
-----------------------------------
Date
LOUIS G. VAN HORN
-----------------------------------
Signature
Louis G. Van Horn,
Vice President and Comptroller
-----------------------------------
Name/Title
<PAGE>
EXHIBIT INDEX
-------------
Exhibit Document Page No.
A Joint Filing Agreement 11
Page 10 of 11
Exhibit A
to
SCHEDULE 13G
Berger Associates, Inc.
and
Kansas City Southern Industries, Inc.
-------------------------------------
Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of
1934, Berger Associates, Inc., a Delaware corporation, and Kansas City
Southern Industries, Inc., a Delaware corporation, hereby agree that
the preceding Schedule 13G is being filed on behalf of each of them.
IN WITNESS WHEREOF, the parties hereto have duly executed this
agreement on this 12th day of February, 1997.
BERGER ASSOCIATES, INC.
KEVIN R. FAY
-------------------------------------
Kevin R. Fay
Sr. Vice President - Finance and
Administration
KANSAS CITY SOUTHERN INDUSTRIES, INC.
LOUIS G. VAN HORN
-------------------------------------
Louis G. Van Horn
Vice President and Comptroller
Page 11 of 11
